Institution: | 1. Science for Life Laboratory, School of Biotechnology, Division of Gene Technology, Royal Institute of Technology, SE-171 65 Solna, Sweden;2. NextBio, 475 El Camino Real, Santa Clara, CA 95050, USA;3. Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Madrid, Spain;4. ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Spain;5. Clinical Pharmacology, Division of Drug Research, Department of Medical and Health Sciences, Faculty of Health Sciences, Linköpings Universitet, SE-581 85 Linköping, Sweden;6. Unidad de Oncología Médica, Fundación Hospital Alcorcón (FHA), Madrid, Spain |